LOS GATOS, CA — November 11, 2025 — Leads & Copy — Tenon Medical, Inc. (NASDAQ:TNON) has announced the pricing of an at-the-market private investment in public equity (PIPE) financing, securing $2,850,000 in gross proceeds.
The PIPE involves several accredited investors, including strategic industry partners and Tenon’s management team, and consists of the issuance of 2,217,904 shares of common stock and warrants to purchase an additional 2,217,904 shares.
Under securities purchase agreements dated September 10, 2025, Tenon will offer these shares and warrants at a combined price of $1.285 per share and warrant. The warrants, termed “PIPE Warrants,” will have an exercise price of $1.16 per share and will expire three years from the date of issuance. Investors will also be granted customary resale registration rights for the issued shares and shares underlying the PIPE Warrants.
Tenon Medical intends to allocate the PIPE proceeds to bolster working capital and for general corporate initiatives, including supporting upcoming product launches, expanding commercial operations, advancing clinical studies, and investing in core business operations.
The securities involved in the PIPE have not been registered under the Securities Act of 1933 or applicable state securities laws and may not be offered or sold in the United States without registration or an applicable exemption.
Tenon Medical, Inc., established in 2012, specializes in medical devices, notably the Catamaran SI Joint Fusion System. This system provides a less invasive approach to sacroiliac (SI) joint fusion, utilizing a single titanium implant designed for stability and fixation. Tenon Medical is focused on three commercial opportunities within the SI Joint market: primary SI Joint procedures, revision procedures for failed SI Joint implants, and augmenting spinal fusion.
The Catamaran SI Joint Fusion System is designed to pass through both the axial and sagittal planes of the ilium and sacrum, stabilizing and transfixing the SI Joint along its longitudinal axis. The surgical approach is also designed to provide a pathway away from critical neural and vascular structures and into the strongest cortical bone.
Trademarks of Tenon Medical, Inc. include the Tenon Medical logo, Catamaran®, PiSIF®, CAT PiSIF®, ETAD®, Posterior Inferior Sacroiliac Fusion®, CAT SIJ Fusion System®, Catamaran SIJ Fusion System®, Catamaran Inferior Posterior Fusion System®, Catamaran Transfixation Fusion System®, Catamaran Transfixation Fusion Device®, and SImmetry®. MAINSAILTM and SImmetry+™ are also trademarks of Tenon Medical, Inc.
Shannon Devine
203-741-8811
MZ North America
tenon@mzgroup.us
Source: Tenon Medical, Inc.
